Does momordica charantia (bitter gourd) improve outcomes in people with type 2 diabetes mellitus?

2012 ◽  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Momordica Charantia ◽  
Bitter Gourd

scholarly journals Momordica charantia for type 2 diabetes mellitus

2010 ◽  
Author(s):  
Cheow Peng Ooi ◽  
Zaitun Yassin ◽  
Tengku-Aizan Hamid
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Momordica Charantia

scholarly journals Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus

2018 ◽  
Vol 21 (7) ◽  
pp. 672-677 ◽  
Author(s):  
Marisol Cortez-Navarrete ◽  
Esperanza Martínez-Abundis ◽  
Karina G. Pérez-Rubio ◽  
Manuel González-Ortiz ◽  
Miriam Méndez-del Villar
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Insulin Secretion ◽  
Momordica Charantia

Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis

2019 ◽  
Vol 231 ◽  
pp. 311-324 ◽  
Author(s):  
Emanuel L. Peter ◽  
Félicien Mushagalusa Kasali ◽  
Serawit Deyno ◽  
Andrew Mtewa ◽  
Prakash B. Nagendrappa ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Meta Analysis ◽  
Momordica Charantia

scholarly journals Immediate effect of bitter gourd, ash gourd, Knol-khol juices on blood sugar levels of patients with type 2 diabetes mellitus: A pilot study

2017 ◽  
Vol 7 (4) ◽  
pp. 526-531 ◽  
Author(s):  
G. Selvakumar ◽  
G. Shathirapathiy ◽  
R. Jainraj ◽  
P. Yuvaraj Paul
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Pilot Study ◽  
Blood Sugar ◽  
Bitter Gourd ◽  
Sugar Levels ◽  
Ash Gourd

scholarly journals The safety and efficacy of Momordica charantia L. in animal models of type 2 diabetes mellitus: A systematic review and meta‐analysis

2020 ◽  
Author(s):  
Emanuel L. Peter ◽  
Prakash B. Nagendrappa ◽  
Anita Kaligirwa ◽  
Patrick Engeu Ogwang ◽  
Crispin Duncan Sesaazi
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Animal Models ◽  
Meta Analysis ◽  
Momordica Charantia ◽  
Safety And Efficacy

scholarly journals Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol

2018 ◽  
Vol 7 (1) ◽  
Author(s):  
Emanuel L. Peter ◽  
Serawit Deyno ◽  
Andrew Mtewa ◽  
Félicien Mushagalusa Kasali ◽  
Prakash B. Nagendrappa ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Meta Analysis ◽  
Momordica Charantia ◽  
Safety And Efficacy ◽  
Analysis Protocol

scholarly journals Systematic review and meta-analysis protocol for efficacy and safety of Momordica charantia L. on animal models of type 2 diabetes mellitus

2020 ◽  
Vol 9 (1) ◽  
Author(s):  
Emanuel L. Peter ◽  
Andrew G. Mtewa ◽  
Prakash B. Nagendrappa ◽  
Anita Kaligirwa ◽  
Crispin Duncan Sesaazi
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Meta Analysis ◽  
Momordica Charantia ◽  
Control Group ◽  
Efficacy And Safety ◽  
Preclinical Models

Abstract Background Studies on several preclinical models of type 2 diabetes mellitus have been conducted to establish the hypoglycemic activity of Momordica charantia L. Concerned with appropriateness of these models, we designed a systematic review to establish the efficacy and safety of M. charantia L. in preclinical models of type 2 diabetes mellitus. Methods Review authors will search without language restriction in MEDLINE/PubMed, Web of Science, Embase, Scopus, and CINAHL databases through April 2019. Search filters will be applied to enhance search efficiency. The authors will search for gray literature in Google and Google Scholar, OpenGrey, and ProQuest Dissertations & Theses. Two authors will evaluate full texts, extract data, and asses risk of bias independently. The review will include randomized or non-randomized studies that assessed the efficacy or safety of M. charantia L. with vehicle control group. The primary endpoint will be fasting blood glucose level. We will use Egger’s test to assess publication biases. Chi-square test and I2 will be used to assess heterogeneity in effect size of the primary outcome. Using RevMan software version 5.3, the authors will perform a meta-analysis of quantitative data. Discussion The strength of evidence will be rated as high, moderate, low, or very low using GRADE framework for animal studies. This systematic review will potentially improve research practice by identifying risks of bias and design features that compromise translatability and contribute to evidence-based clinical trial design. Systematic review registration PROSPERO CRD42019119181

The effect of Momordica charantia capsule preparation on glycemic control in Type 2 Diabetes Mellitus needs further studies

2007 ◽  
Vol 60 (6) ◽  
pp. 554-559 ◽  
Author(s):  
Antonio Miguel Limcaco Dans ◽  
Maria Vanessa C. Villarruz ◽  
Cecilia A. Jimeno ◽  
Mark Anthony U. Javelosa ◽  
Joel Chua ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Momordica Charantia

scholarly journals Momordica charantia for type 2 diabetes mellitus

2012 ◽  
Author(s):  
Cheow Peng Ooi ◽  
Zaitun Yassin ◽  
Tengku-Aizan Hamid
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Momordica Charantia
Sign in / Sign up

Export Citation Format

Share Document